Skip to main content

OptimizeRx Corp

corporate_fare Company Profile

OptimizeRx Corp

OPRX·NASDAQ·Trade & Services·CIK 0001448431

OptimizeRx is a digital healthcare technology company that helps life sciences brands engage with, market to, and support patients and healthcare providers. Founded in 2006 in Rochester, Michigan, as a Nevada corporation, the company initially delivered messages like coupons and co-pays to physicians and pharmacists through electronic health record (EHR) systems and ePrescribing (eRx) platforms. Over time, OptimizeRx expanded its solutions to deliver a wider variety of health-related information across more platforms and to broader audiences. The company enhanced its original financial messaging solution by incorporating artificial intelligence (AI)-driven tools. Its current AI-enabled Dynamic Audience Activation Platform (DAAP) identifies precise healthcare provider (HCP) audiences and estimates when these HCPs will see brand-eligible patients. In 2023, OptimizeRx acquired Healthy Offers, Inc. (d/b/a "Medicx" or "Medicx Health"), which expanded its capabilities to include direct-to-consumer (DTC) marketing. This DTC marketing uses Medicx Health's patent-protected Micro-Neighborhood® Targeting (MNT) solution. MNT uses de-identified claims data to identify and target geographies where eligible patients live, rather than individual patients, providing a privacy-centric approach for brand manufacturers. With the integration of DTC marketing, OptimizeRx's life sciences brand customers can now reach both HCP and patient audiences across its omnichannel network. The company currently offers diverse tech-enabled marketing solutions that use machine learning algorithms to find the best audience in the correct channels at the right time.

OptimizeRx Corp (NASDAQ:OPRX) is a publicly traded company in the Trade & Services sector. Wiseek monitors OPRX SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Shareholders Approve 1M Equity Plan Shares, Reject Evergreen Dilution Provision
  • OptimizeRx Details CCO Separation Agreement, $589K Payout
  • OptimizeRx Urges Shareholder Approval for Evergreen Equity Plan, Allowing Over 30% Potential Dilution
  • OptimizeRx Reports Reduced Q1 Loss, Achieves Operating Income, Details Debt Refinancing
  • OptimizeRx Secures $35M Senior Secured Facilities from Fifth Third Bank, Refinancing Debt

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$109.43M
Net Income
$5.13M
Diluted EPS
$0.27
Op. Cash Flow
$18.71M
Free Cash Flow
$18.66M
Gross Profit
$73.59M
Operating Income
$11.69M
Cash & Equivalents
$23.36M
Total Debt
$25.68M
Debt / Equity
0.20×
Net Margin
4.7%
Shares Outstanding
18.76M sh
Source: 10-K · filed 2026-03-12 · accession 0001448431-26-000005
Browse all tickers starting with O →
$5.19 -0.04% today
52-week range · as of 2026-06-12 $4.57 – $22.25
Market cap
$98.14M
Volume
152.5K (0.3× avg)
3-mo avg 466.9K
Live data · 2026-06-14 03:53 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed OPRX - Latest Insights

OPRX
Jun 12, 2026, 4:10 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $5.23
Real-time Price: $5.19 info
Change: -$0.040 (-0.76%) info
Market Cap: $98.141M info
OPRX
Jun 05, 2026, 4:10 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $5.11
Real-time Price: $5.19 info
Change: +$0.080 (+2%) info
Market Cap: $98.141M info
OPRX
Jun 01, 2026, 7:30 AM EDT
Filing Type: DEFA14A
Importance Score:
8
Price at Filing: $5.17
Real-time Price: $5.19 info
Change: +$0.020 (+0.39%) info
Market Cap: $98.141M info
OPRX
May 13, 2026, 4:04 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $4.92
Real-time Price: $5.19 info
Change: +$0.270 (+5%) info
Market Cap: $98.141M info
OPRX
May 12, 2026, 4:13 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $6.10
Real-time Price: $5.19 info
Change: -$0.910 (-15%) info
Market Cap: $98.141M info
OPRX
May 12, 2026, 4:07 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $5.75
Real-time Price: $5.19 info
Change: -$0.560 (-10%) info
Market Cap: $98.141M info
OPRX
May 12, 2026, 4:01 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $6.34
Real-time Price: $5.19 info
Change: -$1.15 (-18%) info
Market Cap: $98.141M info
OPRX
Apr 30, 2026, 7:15 AM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $6.43
Real-time Price: $5.19 info
Change: -$1.24 (-19%) info
Market Cap: $98.141M info
OPRX
Apr 08, 2026, 5:46 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $7.07
Real-time Price: $5.19 info
Change: -$1.88 (-27%) info
Market Cap: $98.141M info
OPRX
Mar 12, 2026, 4:03 PM EDT
Filing Type: 10-K
Importance Score:
8
Price at Filing: $5.93
Real-time Price: $5.19 info
Change: -$0.740 (-12%) info
Market Cap: $98.141M info
OPRX
Mar 05, 2026, 5:04 PM EST
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $7.83
Real-time Price: $5.19 info
Change: -$2.64 (-34%) info
Market Cap: $98.141M info
OPRX
Mar 05, 2026, 4:09 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $7.82
Real-time Price: $5.19 info
Change: -$2.63 (-34%) info
Market Cap: $98.141M info